Notably, consistent with the frequent ERBB2 mutational discordance between primary and metastatic tumor samples, three patients in our real-world cohort had discordance of ERBB2 mutational status between cfDNA and archival tumor tissue (Fig. 6A). The gene discussed is ERBB2; the disease is metastatic neoplasm.